Literature DB >> 2949903

Cerebral amyloid angiopathy in Down's syndrome.

M G Belza, H Urich.   

Abstract

We have presented a case report of a 56-year-old Mongoloid female with clinical and pathologic evidence of Alzheimer's disease concurrent with cerebral amyloid angiopathy (CAA) and intracerebral hemorrhage. Although this quartet of events might be expected to have coincided in a single patient, we believe this is the first reported case to present in such a fashion. Because of the high incidence of hemorrhage associated with CAA and the even higher incidence of CAA in Down's syndrome patients, the finding of stroke in this population should be considered secondary to this process until proven otherwise.

Entities:  

Mesh:

Year:  1986        PMID: 2949903

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  16 in total

Review 1.  Genetic animal models of cerebral vasculopathies.

Authors:  Jeong Hyun Lee; Brian J Bacskai; Cenk Ayata
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 2.  Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome.

Authors:  Donna M Wilcock; Frederick A Schmitt; Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2015-11-26

Review 3.  Neuropathological correlates of amyloid PET imaging in Down syndrome.

Authors:  Eric E Abrahamson; Elizabeth Head; Ira T Lott; Benjamin L Handen; Elliott J Mufson; Bradley T Christian; William E Klunk; Milos D Ikonomovic
Journal:  Dev Neurobiol       Date:  2019-08-17       Impact factor: 3.964

Review 4.  Down syndrome, beta-amyloid and neuroimaging.

Authors:  Elizabeth Head; Alex M Helman; David Powell; Frederick A Schmitt
Journal:  Free Radic Biol Med       Date:  2017-09-19       Impact factor: 7.376

Review 5.  Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy.

Authors:  Vitaly Vasilevko; Giselle F Passos; Daniel Quiring; Elizabeth Head; Richard C Kim; Mark Fisher; David H Cribbs
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

Review 6.  Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.

Authors:  Elizabeth Head; Ira T Lott; Donna M Wilcock; Cynthia A Lemere
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

7.  Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database.

Authors:  John M Ringman; Sarah Monsell; Denise W Ng; Yan Zhou; Andy Nguyen; Giovanni Coppola; Victoria Van Berlo; Mario F Mendez; Spencer Tung; Sandra Weintraub; Marek-Marsel Mesulam; Eileen H Bigio; Darren R Gitelman; Amanda O Fisher-Hubbard; Roger L Albin; Harry V Vinters
Journal:  J Neuropathol Exp Neurol       Date:  2016-02-17       Impact factor: 3.685

8.  New onset focal weakness in children with Down syndrome.

Authors:  Gordon Worley; Rolla Shbarou; Amy N Heffner; Karin M Belsito; George T Capone; Priya S Kishnani
Journal:  Am J Med Genet A       Date:  2004-07-01       Impact factor: 2.802

Review 9.  Dementia in Down syndrome: unique insights for Alzheimer disease research.

Authors:  Ira T Lott; Elizabeth Head
Journal:  Nat Rev Neurol       Date:  2019-03       Impact factor: 42.937

Review 10.  Hereditary and sporadic forms of abeta-cerebrovascular amyloidosis and relevant transgenic mouse models.

Authors:  Samir Kumar-Singh
Journal:  Int J Mol Sci       Date:  2009-04-23       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.